Description
BSE announces listing of Commercial Paper issued by Standard Chartered Capital Limited on private placement basis, with two tranches totaling 4000 units of Rs.5 lakh each.
Summary
BSE has listed new Commercial Paper issued by Standard Chartered Capital Limited on private placement basis. Two tranches totaling 4000 units (face value Rs.5 lakh each) have been admitted to dealings on the BSE Debt segment effective October 6, 2025. The securities are rated CRISIL A1+ and ICRA A1+, with redemption scheduled for June 11, 2026.
Key Points
- Issuer: Standard Chartered Capital Limited
- Instrument: Commercial Paper (private placement)
- Total Quantity: 4000 units across two tranches (2000 units each)
- Face Value: Rs.5,00,000 per unit
- Scrip Code: 730351
- Scrip ID: SCCL031025
- ISIN: INE403G14TP6
- Credit Rating: CRISIL A1+, ICRA A1+
- Market Lot: 1 unit
- Tick Size: 1 paise
- Trading Mode: Dematerialised form only
- Standard Denomination: Rs.5 lakhs and multiples thereof
- Issuing and Paying Agent: HDFC Bank Limited
Tranche Details
Tranche 1
- Issue Price: Rs.4,76,724.00
- Allotment Date: October 3, 2025
- Redemption Date: June 11, 2026
- Quantity: 2000 units
Tranche 2
- Issue Price: Rs.4,76,989.50
- Allotment Date: October 6, 2025
- Redemption Date: June 11, 2026
- Quantity: 2000 units (further listing under same ISIN)
Regulatory Changes
No regulatory changes introduced in this circular.
Compliance Requirements
- Trading members must trade these securities only in dematerialised form under ISIN INE403G14TP6
- Trading shall take place in standard denomination of Rs.5 lakhs and multiples thereof
- Tick size for the securities is 1 paise
Important Dates
- Listing Date: October 6, 2025
- First Allotment Date: October 3, 2025
- Second Allotment Date: October 6, 2025
- Redemption Date: June 11, 2026
Impact Assessment
This is a routine debt instrument listing with minimal market impact. Commercial Paper is a short-term debt instrument typically used by financial institutions for treasury management. The listing provides additional liquidity options for institutional investors in the debt market segment. No impact on equity markets or retail investors. Contact debt department at BSE (22728352/8597/8995/5753/8915) for clarifications.
Impact Justification
Routine commercial paper listing for institutional debt instrument with no impact on equity markets or retail investors